Garnham Byron M, Fitzpatrick-Wong Shirley, Schunack Walter, Nürnberg Bernd, Sorrentino Giuseppe, Parkinson Fiona E, Kanfer Julian N, Sitar Daniel S
Department of Pharmacology and Therapeutics, University of Manitoba, A220-770 Bannatyne Avenue, Winnipeg, MB, Canada R3E 0W3.
Neurochem Res. 2002 Dec;27(12):1613-8. doi: 10.1023/a:1021626825394.
Compound 24, an alkyl-substituted amino acid amide, previously found to activate pertussis toxin-sensitive G proteins in cell membranes and membrane protein fractions, was used as a tool to determine the mechanism/location of nicotine inhibition of amyloid beta peptide-stimulated phospholipase A2 and D activities in a human neuroblastoma cell line, LA-N-2, in vitro. In contrast to our previous findings with amyloid beta peptide, these phospholipase activations by compound 24 were not inhibited by (-)-nicotine, cholera toxin or tetanus toxin pretreatment. The contrasting activation of these phospholipases by amyloid beta peptide and compound 24 are discussed.